Conference Paper

Delivering real-time satellite data to a broader audience

DOI: 10.1145/1658260.1658264 Conference: Proceedings of the 5th Grid Computing Environments Workshop, GCE 2009, November 20, 2009, Portland, Oregon, USA
Source: DBLP

ABSTRACT

This paper presents our work of enhancing the existing cyberinfrastructure using Web 2.0 technologies for delivering real time satellite data to a broader audience. As a resource provider on the TeraGrid, Purdue University hosts several data collections for earth and environmental research, including a large number of satellite data products that are received and generated in real time at the Purdue Terrestrial Observatory (PTO). A science gateway portal, named PRESTIGE, has been developed as the access point to services related to the satellite data generated at PTO. It remains a major challenge to help potential users easily discover the data products that are available and access them based on their needs. In an effort to address this challenge, we developed different interfaces for different user groups. We use the Google gadget as a new way to deliver satellite data and information to a broad user community. Three satellite data viewer gadgets have been developed and deployed. They connect to a data generation and processing system at the backend. The gadgets embrace the recent Web 2.0 technologies in bringing the rich access and sharing capabilities available in the general cyberspace to the scientific user communities.

Download full-text

Full-text

Available from: Carol X. Song, Sep 22, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Platelet-derived growth factor-D (PDGF-D) can regulate many cellular processes, including cell proliferation, apoptosis, transformation, migration, invasion, angiogenesis and metastasis. Therefore PDGF-D signaling has been considered to be important in human malignancies, and thus PDGF-D signaling may represent a novel therapeutic target, and as such suggests that the development of agents that will target PDGF-D signaling is likely to have a significant therapeutic impact on human cancers. This mini-review describes the mechanisms of signal transduction associated with PDGF-D signaling to support the role of PDGF-D in the carcinogenesis. Moreover, we summarize data on several PDGF-D inhibitors especially naturally occurring "chemopreventive agent" such an indole compound, which we believe could serve as a novel agent for the prevention of tumor progression and/or treatment of human malignancies by targeted inactivation of PDGF-D signaling.
    Full-text · Article · Aug 2010 · Biochimica et Biophysica Acta
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Formation of new blood vessels (angiogenesis) has been demonstrated to be a basic prerequisite for sustainable growth and proliferation of tumor. Several growth factors, cytokines, small peptides and enzymes support tumor growth either independently or in synergy. Decoding the crucial mechanisms of angiogenesis in physiological and pathological state has remained a subject of intense interest during the past three decades. Currently, the most widely preferred approach for arresting tumor angiogenesis is the blockade of vascular endothelial growth factor (VEGF) pathway; however, the clinical usage of this modality is still limited by several factors like adverse effects, toxicity, acquired drug resistance, non availability of valid biomarkers etc. Nevertheless, angiogenesis, being a normal physiological process imposes limitations in maneuvering it as therapeutic target for tumor angiogenesis. The present review offers an updated relevant literature describing the role of well-characterized angiogenic factors, such as VEGF, basic fibroblast growth factor (bFGF), platelet derived growth factor (PDGF), placenta growth factor (PLGF), hepatocyte growth factor/scatter factor (HGF/SF) and angiopoetins (ANGs) in regulating tumor angiogenesis. We have also attempted to discuss tumor angiogenesis with a perspective of ‘an attractive target with emerging challenges’, along with the limitations and present status of anti-angiogenic therapy in the current state-of-the-art.
    Full-text · Article · May 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.